K261467 is an FDA 510(k) clearance for the GT Metabolic Magnet System (MAG-04, DS-01)GT Metabolic Magnet System (MAG-05,.... Classified as Magnetic Compression Anastomosis System (product code SAH), Class II - Special Controls.
Submitted by Gt Metabolic Solutions, Inc. (St. Michael, US). The FDA issued a Cleared decision on September 16, 2026 after a review of 135 days - within the typical 510(k) review window.
This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4816 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.
View all Gt Metabolic Solutions, Inc. devices
NCT06073457
Active not recruiting
Interventional
Industry-sponsored
Magnetic Gastro-Ileal or Gastro-Jejunal Diversion Study ("MGI/MGJ Study")
Creation of Side-to-Side Compression Anastomosis Using the GT Metabolic Solutions Magnet System, GJ Biofragmentable to Achieve Gastro-Ileal or Gastro-Jejunal Diversion in Adults With Obesity
| Condition studied |
Obesity; Type 2 Diabetes |
| Study design |
Single group |
| Eligibility |
All sexes
· 18 Years+
|
| Sponsor |
GT Metabolic Solutions, Inc.
(industry)
|
Started 2023-11-06
→
Primary completion 2026-04-17
→
Completed 2027-01-01
Primary outcome
Magnet Placement
View full study on ClinicalTrials.gov